Literature DB >> 2491013

Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.

H Payami1, S Joe, N R Farid, V Stenszky, S H Chan, P P Yeo, J S Cheah, G Thomson.   

Abstract

A method is described to reveal the relative predispositional effects (RPEs) (predisposing, protective, or neutral) of the HLA alleles or of any other marker system that is associated with a disease. When the disease is associated with two or more alleles of a locus, the RPE method identifies the associations sequentially according to their strength; thus the problem that a strong association with one allele can create misleading deviations in the frequencies of other alleles is alleviated. Using this method, we have examined the relative effects of HLA-DR alleles in susceptibility to Graves disease in the Caucasian population. The well-established positive association with DR3 was confirmed as the strongest effect. In addition, a negative association was found between DR5 and Graves disease. The reduced frequency of DR5 among patients is statistically significant and is not a result of the increase in DR3. Finally, when patients were divided according to the presence or absence of eye disease, the latter showed a significant increase in the frequency of DR4. With family data, linkage to HLA of Graves disease was established in both Caucasian and Chinese families by the sib-pair method.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2491013      PMCID: PMC1683504     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  HLA and IDDM predisposition: new aspects.

Authors:  G Thomson; W Klitz; E J Louis; S K Lo; J Bertrams; M Baur; M Neugebauer
Journal:  Genet Epidemiol Suppl       Date:  1986

3.  HlA haplotype sharing in affected siblings in multiple case Chinese families with thyrotoxicosis.

Authors:  S H Chan; P P Yeo; J S Cheah; P Lim
Journal:  Tissue Antigens       Date:  1980-09

4.  The affected sib method. II. The intermediate model.

Authors:  E J Louis; G Thomson; H Payami
Journal:  Ann Hum Genet       Date:  1983-07       Impact factor: 1.670

5.  The affected sib method. I. Statistical features of the affected sib-pair method.

Authors:  U Motro; G Thomson
Journal:  Genetics       Date:  1985-07       Impact factor: 4.562

6.  HLA antigens in Graves' disease.

Authors:  K Bech; B Lumholtz; J Nerup; M Thomsen; P Platz; L P Ryder; A Svejgaard; K Siersbaek-Nielsen; J M Hansen; J H Larsen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-11

Review 7.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.

Authors:  G Thomson; W P Robinson; M K Kuhner; S Joe; M J MacDonald; J L Gottschall; J Barbosa; S S Rich; J Bertrams; M P Baur
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

8.  A study of human leukocyte D locus related antigens in Graves' disease.

Authors:  N R Farid; L Sampson; E P Noel; J M Barnard; R Mandeville; B Larsen; W H Marshall; N D Carter
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

9.  HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.

Authors:  H Schleusener; G Schernthaner; W R Mayr; P Kotulla; U Bogner; R Finke; H Meinhold; K Koppenhagen; K W Wenzel
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

10.  HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus.

Authors:  G Thomson
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

View more
  47 in total

1.  The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families.

Authors:  J A Noble; A M Valdes; M Cook; W Klitz; G Thomson; H A Erlich
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

2.  The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.

Authors:  O Olerup; M Schaffer; J Hillert; C Sachs
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls.

Authors:  M K Hockertz; D W Paty; S S Beall
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

Authors:  Yali Cao; John L Schmitz; Jiajin Yang; Susan L Hogan; Donna Bunch; Yichun Hu; Caroline E Jennette; Elisabeth A Berg; Frank C Arnett; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

5.  PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis.

Authors:  Victoria E H Carlton; Xiaolan Hu; Anand P Chokkalingam; Steven J Schrodi; Rhonda Brandon; Heather C Alexander; Monica Chang; Joseph J Catanese; Diane U Leong; Kristin G Ardlie; Daniel L Kastner; Michael F Seldin; Lindsey A Criswell; Peter K Gregersen; Ellen Beasley; Glenys Thomson; Christopher I Amos; Ann B Begovich
Journal:  Am J Hum Genet       Date:  2005-08-10       Impact factor: 11.025

6.  Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis.

Authors:  Glenys Thomson; Nishanth Marthandan; Jill A Hollenbach; Steven J Mack; Henry A Erlich; Richard M Single; Matthew J Waller; Steven G E Marsh; Paula A Guidry; David R Karp; Richard H Scheuermann; Susan D Thompson; David N Glass; Wolfgang Helmberg
Journal:  Pac Symp Biocomput       Date:  2010

7.  HLA class II and T-cell receptor beta chain polymorphisms in Belgian patients with rheumatoid arthritis: no evidence for disease association with the TCRBC2, TCRBV8 and TCRBV11 polymorphisms.

Authors:  C Vandevyver; X X Gu; P Geusens; M Spaepen; L Philippaerts; J J Cassiman; J Raus
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

8.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.

Authors:  K Hartung; M P Baur; R Coldewey; M Fricke; J R Kalden; H J Lakomek; H H Peter; D Schendel; P M Schneider; S A Seuchter
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort.

Authors:  X Wu; V Kondragunta; K S Kornman; H Y Wang; G W Duff; J B Renner; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2013-04-18       Impact factor: 6.576

10.  High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions.

Authors:  Lisa F Barcellos; Suzanne L May; Patricia P Ramsay; Hong L Quach; Julie A Lane; Joanne Nititham; Janelle A Noble; Kimberly E Taylor; Diana L Quach; Sharon A Chung; Jennifer A Kelly; Kathy L Moser; Timothy W Behrens; Michael F Seldin; Glenys Thomson; John B Harley; Patrick M Gaffney; Lindsey A Criswell
Journal:  PLoS Genet       Date:  2009-10-23       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.